Robert Cohen
Family Medicine · Delray Beach, FLNPI 1083687610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $617 and has fallen 95.9% since, to $25 in 2025.
Across 97 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$192
- Amarin Pharma, Inc.$159
- Almatica Pharma LLC$152
- Pfizer$151
- Exact Sciences$128
- Amgen$113
- plus $863 from 23 others
Across 90 payments — averaging $7024.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$269K
- Novartis$198K
- Eli Lilly$83K
- Pfizer$28K
- Merck$15K
- AstraZeneca$13K
- plus $26K from 4 others
What the payments were for
- Food & beverage$1,758100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $192 |
| Amarin Pharma, Inc. | 9 | $159 |
| Almatica Pharma LLC | 7 | $152 |
| Pfizer | 9 | $151 |
| Exact Sciences | 6 | $128 |
| Amgen | 7 | $113 |
| AbbVie(2 entities) | 5 | $83 |
| GSK | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Novartis | 4 | $66 |
| Merck | 4 | $56 |
| Lucid Diagnostics Inc. | 3 | $50 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Johnson & Johnson | 3 | $49 |
| Medtronic(2 entities) | 2 | $47 |
| Kowa Pharmaceuticals America, Inc. | 2 | $39 |
| Boston Scientific | 2 | $35 |
| Biosense Webster, Inc. | 1 | $34 |
| Shield Therapeutics Inc | 1 | $29 |
| Abiomed | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $12 |
How this compares
$1,758 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $16,662 |
| Levothyroxine Sodium | 225 | $2,127 |
| SynthroidLevothyroxine Sodium | 24 | $1,987 |
| Atorvastatin Calcium | 180 | $1,861 |
| Silodosin | 11 | $1,553 |
| Rosuvastatin Calcium | 100 | $1,191 |
| Losartan Potassium | 96 | $1,035 |
| Simvastatin | 130 | $985 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $853 |
| Omeprazole | 85 | $779 |
| Ezetimibe | 22 | $764 |
| Amlodipine Besylate | 139 | $732 |
| Metoprolol Succinate | 47 | $704 |
| Escitalopram Oxalate | 59 | $678 |
| Pantoprazole Sodium | 50 | $579 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $151 | $16,66212 claims |
| AbbVieSynthroid | $83 | $1,98724 claims |
| Almatica Pharma LLCSertraline Hcl | $152 | $12923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Delray Beach
- Noah LeeOakland Park$1.2M
- Angela RosselotBelle Isle$977K
- Richard LappOrlando$702K
- Hal BrownVero Beach$477K
- Lisa EvansBoca Raton$473K
- Giovana Rene CrooksBoca Raton$407K
- Edward BraunSt Petersburg$364K
- Samuel GreenleePensacola$235K
- Kevin FitzgeraldStuart$198K
- Louis KuritzkyGainesville$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.